PMID: 630325Mar 25, 1978

Haemoglobin AIc concentrations after initial insulin treatment for newly discovered diabetes

British Medical Journal
J Ditzel, J J Kjaergaard

Abstract

Glycosylated haemoglobins AIa+Ib and AIc were measured serially in 10 consecutive cases of newly discovered non-acidotic diabetes before and after diet and insulin treatment. The average concentration of Hb AIc was 11.4% in untreated diabetics as compared with 4.3% in healthy controls. With prolonged optimal regulation of blood glucose Hb AIc slowly decreased to a mean concentration of 5.5%. The concentration of Hb AIc was significantly correlated with the fasting blood sugar value. The findings suggest that determining Hb AIc may give valuable information on the regulation of carbohydrate metabolism in the preceding one to two months and thus become an important aid to management.

References

Apr 1, 1982·Diabetologia·B VialettesP Vague
Aug 1, 1980·European Journal of Pediatrics·W Schröter
Jan 1, 1981·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·F D GoebelC Kolmar
Apr 1, 1984·Acta diabetologica latina·J Ditzel, T Jensen
Feb 1, 1982·Irish Journal of Medical Science·P D MayneR R O'Moore
Feb 1, 1981·Clinical Biochemistry·T M JamesJ H Ladenson
Feb 1, 1990·Journal of Internal Medicine·P Gram-HansenL Olesen
Apr 1, 1979·Archives of Disease in Childhood·M L Williams, D C Savage
Jul 7, 1979·British Medical Journal·R D LeslieJ M White
Jul 28, 1979·British Medical Journal·A P BrooksI M Nairn
Sep 13, 1980·British Medical Journal·A P BrooksJ D Baird
Nov 15, 1980·British Medical Journal
Sep 19, 1981·British Medical Journal·V A Fonseca
Jan 1, 1981·Journal of Endocrinological Investigation·M TrovatiG Lenti
May 27, 1978·British Medical Journal
May 24, 1980·Lancet·M D BaronP H Sönksen
Nov 29, 2005·Endocrinology and Metabolism Clinics of North America·Lois Jovanovic, Yuichiro Nakai
Jul 1, 1980·Acta paediatrica Scandinavica·A PollakE Schober
Sep 5, 2006·Journal of Diabetes and Its Complications·Siv M Osterman-Golkar, Hubert W Vesper
Jan 10, 2012·Journal of Diabetes Science and Technology·Konstantinos Makris, Loukia Spanou
Sep 18, 1987·The American Journal of Medicine·S L SchwartzM Boyle
Feb 1, 1981·The American Journal of Medicine·T A SchultzM M Bliziotes
Nov 15, 1980·British Medical Journal
Mar 1, 1979·British Journal of Obstetrics and Gynaecology·T Lind, G A Cheyne
Jul 1, 1979·Acta paediatrica Scandinavica·E HeinzeE Kleihauer
Nov 1, 1979·Acta paediatrica Scandinavica·J Ludvigsson, P G Svensson
Mar 2, 1981·Klinische Wochenschrift·T GainP Bottermann
May 1, 1982·Scandinavian Journal of Clinical and Laboratory Investigation·H ArnqvistS Wettre
Dec 1, 1983·Scandinavian Journal of Clinical and Laboratory Investigation·S WettreH von Schenck
Jul 2, 2014·Medicine and Science in Sports and Exercise·Semah TagouguiElsa Heyman
Jan 1, 1981·Acta Medica Scandinavica. Supplementum·B AhrénB Scherstén
Mar 1, 1981·Drug Intelligence & Clinical Pharmacy·M S TorreR A Mangione
Jan 1, 1987·Annals of Clinical Biochemistry·R D ForrestJ S Yudkin

Citations

Oct 1, 1975·Diabetes·D E McMillan
May 1, 1977·The Journal of Clinical Endocrinology and Metabolism·K H GabbayP M Gallop
Aug 19, 1976·The New England Journal of Medicine·R J KoenigA Cerami
Mar 1, 1975·Acta paediatrica Scandinavica·J DitzelN D Peters
Jun 1, 1970·The Journal of Clinical Investigation·H F Bunn, R W Briehl
Feb 18, 1971·The New England Journal of Medicine·L A TrivelliH T Lai

Related Concepts

Epicholesterol
Eryhem
Novolin
Glycosuria
Diabetes Mellitus
Hemoglobin A
Diabetic Diet
Triglycerides
Blood Glucose

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.